AbbVie
ABBV
ABBV
2,060 hedge funds and large institutions have $95.6B invested in AbbVie in 2018 Q4 according to their latest regulatory filings, with 222 funds opening new positions, 681 increasing their positions, 895 reducing their positions, and 100 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
1% less ownership
Funds ownership: 70.52% → 69.52% (-1%)
5% less capital invested
Capital invested by funds: $101B → $95.6B (-$5.47B)
24% less repeat investments, than reductions
Existing positions increased: 681 | Existing positions reduced: 895
Holders
2,060
Holding in Top 10
148
Calls
$1.13B
Puts
$1.2B
Top Buyers
| 1 | +$384M | |
| 2 | +$249M | |
| 3 | +$187M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$168M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$117M |
Top Sellers
| 1 | -$556M | |
| 2 | -$428M | |
| 3 | -$237M | |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$210M |
| 5 |
Barclays
London,
United Kingdom
|
-$198M |